BlueSky Capital invests in Medimetry

Medimetry, which offers an online platform for telemedicine, electronic medical records and disease management, has raised an undisclosed amount in seed funding led by US-headquartered hedge fund BlueSky Capital Management. BlueSky Capital Management is the parent of Exponential Innovation Fund-I, a Category I alternative investment fund registered with the Securities and Exchange Board of India (SEBI) and managed by investment advisory firm 3737 North Capital LLC. Krishan Tyagi, Co-founder and CEO, Medimetry, said the company will use the fresh capital for sales, marketing and to upgrade its digital disease management platform. Medimetry was founded in 2016 by Tyagi, an Indian Institute of Technology and Indian Institute of Management graduate, and his wife Bhawana. The company started out as an online doctor consultation platform that connects doctors with patients in real time. It is now building a digital disease management platform for chronic ailments.